Abstract
Cyanobacteria are photosynthetic prokaryotes that have a variety of biological activities and can be used as dietary supplements. Because of its high nutritional, protein, and digestibility content, it is utilized as a meal supplement. Spirulina sp., Anabaena sp., Microcystis sp., Nostoc sp., Lyngbya sp., Oscillatoria sp., and other cyanobacteria create a wide range of secondary bioactive metabolites with diverse biological functions. Cyanobacteria produce various physiologically active and chemically diverse compounds such as saccharides, fatty acid amides, lipopeptides, cyclic and acyclic peptides, and alkaloids. More than half of marine cyanobacteria could be used to extract bioactive compounds that can destroy cancer cells by causing apoptosis. Their effectiveness as an antiviral, antitumor, antibacterial, anti-HIV, and dietary additive is extensively documented. However, such drugs are in various phases of clinical studies, and only a few have made it to the market. This chapter examines the bioactive chemicals in cyanobacteria with antiprotozoal, antibacterial, anti-inflammatory, anticancer, antioxidant, and antiviral properties.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abd El-Hack ME, Abdelnour S, Alagawany M, Abdo M, Sakr MA, Khafaga AF, Gebriel MG (2019) Microalgae in modern cancer therapy: current knowledge. Biomed Pharmacother 111:42–50
Asthana RK, Srivastava A, Kayastha AM, Nath G, Singh SP (2006) Antibacterial potential of γ-linolenic acid from Fischerella sp. colonizing neem tree bark. World J Microbiol Biotechnol 22:443–448
Baran PS, Richter JM (2005) Enantioselective total syntheses of welwitindolinone A and fischerindoles I and G. J Am Chem Soc 127:15394–15396
Becher PG, Beuchat J, Gademann K, Jüttner F (2005) Nostocarboline: isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A. J Nat Prod 68:1793–1795
Belay A (2002) The potential application of Spirulina (Arthrospira) as a nutritional and therapeutic supplement in health management. J Am Nutraceutical Assoc 5:27–48
Bhaskar SU, Gopalaswamy G, Raghu R (2005) A simple method for efficient extraction and purification of C-phycocyanin from Spirulina platensis Geitler
Bin ZS, Hussain MA, Nye R, Mehta V, Mamun KT, Hossain N (2017) A review on antibiotic resistance: alarm bells are ringing. Cureus. Available from: https://doi.org/10.7759/cureus.1403
Bokesch HR, O'Keefe BR, McKee TC, Pannell LK, Patterson GM, Gardella RS, Boyd MR (2003) A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium. Biochemistry 42:2578–2584
Burja AM, Banaigs B, Abou-Mansour E, Burgess JG, Wright PC (2001) Marine cyanobacteria—a prolific source of natural products. Tetrahedron 57:9347–9377
Cane DE, Walsh CT (1999) The parallel and convergent universes of polyketide synthases and nonribosomal peptide synthetases. Chem Biol 6:R319–R325
Challem JJ, Passwater RA, Mindell EM (1981) Spirulina. Keats Publishing, New Canaan, CT
Chauhan A, Chauhan G, Gupta PC, Goyal P, Kaushik P (2010) In vitro antibacterial evaluation of Anabaena sp. against several clinically significant microflora and HPTL Canalysis of its active crude extracts. Indian J Pharmacol 42:105–107
Cherng SC, Cheng SN, Tarn A, Chou TC (2007) Anti-inflammatory activity of c-phycocyanin in lipopolysaccharide-stimulated RAW 264.7 macrophages. Life Sci 81:1431–1435
Ciferri O (1983) Spirulina, the edible microorganism. Microbiol Rev 47:551–578
Clark BR, Engene N, Teasdale ME, Rowley DC, Matainaho T, Valeriote FA, Gerwick WH (2008) Natural products chemistry and taxonomy of the marine cyanobacterium Blennothrix cantharidosmum. J Nat Prod 71:1530–1537
Cohen Z, Reungjitchachawali M, Siangdung W, Tanticharoen M (1993) Production and partial purification of γ-linolenic acid and some pigments from Spirulina platensis. J Appl Phycol 5:109–115
Davidson BS (1995) New dimensions in natural products research: cultured marine microorganisms. Curr Opin Biotechnol 6:284–291
De la Coba F, Aguilera J, De Galvez MV, Alvarez M, Gallego E, Figueroa FL, Herrera E (2009) Prevention of the ultraviolet effects on clinical and histopathological changes, as well as the heat shock protein-70 expression in mouse skin by topical application of algal UV-absorbing compounds. J Dermatol Sci 55:161–169
Demay J, Bernard C, Reinhardt A, Marie B (2019) Natural products from cyanobacteria: focus on beneficial activities. Mar Drugs 17:320
Eriksen NT (2008) Production of phycocyanin-a pigment with applications in biology, biotechnology, foods and medicine. Appl Microbiol Biotechnol 80:1–14
Estela Silva-Stenico M, Kaneno R, Zambuzi F, Vaz M, Alvarenga D, Fiore M (2013) Natural products from cyanobacteria with antimicrobial and antitumor activity. Curr Pharm Biotechnol 14:820–828
Euler US, Eliassen R (1967) Prostaglandins. Academic Press, New York
Fernández-Prada C, Douanne N, Minguez-Menendez A, Pena J, Tunes LG, Pires DE, Monte-Neto RL (2019) Repurposed molecules: a new hope in tackling neglected infectious diseases. In: Silico drug design, pp 119−160
Ghanbari R (2019) Review on the bioactive peptides from marine sources: indication for health effects. Int J Pept Res Ther 25:1187–1199
Harrigan GG, Yoshida WY, Moore RE, Nagle DG, Park PU, Biggs J, Valeriote FA (1998) Isolation, structure determination, and biological activity of dolastatin 12 lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages. J Nat Prod 61:1221–1225
Hayashi O, Hirahashi T, Katoh T, Miyajima H, Hirano T, Okuwaki Y (1998) Class-specific influence of dietary Spirulina platensis on antibody production in mice. J Nutr Sci Vitaminol 44:841–851
Hernández-Corona A, Nieves I, Meckes M, Chamorro G, Barron BL (2002) Antiviral activity of Spirulina maxima against herpes simplex virus type 2. Antivir Res 56:279–285
Horrobin DF (2000) Essential fatty acid metabolism and modification in atopic eczema. Am J Clin Nutr 71:367–372
Jenke-Kodama H, Sandmann A, Müller R, Dittmann E (2005) Evolutionary implications of bacterial polyketide synthases. Mol Biol Evol 22:2027–2039
Jensen GS, Ginsberg DI, Huerta P, Citton M, Drapeau C (2000) Consumption of Aphanizomenon flos-aquae has rapid effects on the circulation and function of immune cells in humans. JANA 2:50–58
Jones AC, Gu L, Sorrels CM, Sherman DH, Gerwick WH (2009) New tricks from ancient algae: natural products biosynthesis in marine cyanobacteria. Curr Opin Chem Biol 13:216–223
Kanekiyo K, Hayashi K, Takenaka H, Lee JB, Hayashi T (2007) Anti-herpes simplex virus target of an acidic polysaccharide, nostoflan, from the edible blue-green alga Nostoc flagelliforme. Biol Pharm Bull 30:1573–1575
Kapuścik A, Hrouzek P, Kuzma M, Bártová S, Novák P, Jokela J, Kopecký J (2013) Novel Aeruginosin-865 from Nostoc sp. as a potent anti-inflammatory agent. Chem Bio Chem 14:2329–2337
Kernoff PB, Willis A, Stone KJ, Davies JA, McNicol GP (1977) Antithrombotic potential of dihomogamma-linolenic acid in man. Br Med J 2:1441–1444
Khandia R, Dadar M, Munjal A, Dhama K, Karthik K, Tiwari R, Chaicumpa W (2019) A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: current knowledge and prospects for disease prevention, novel drug design, and therapy. Cell 8:674
Kini S, Divyashree M, Mani MK, Mamatha BS (2020) Algae and cyanobacteria as a source of novel bioactive compounds for biomedical applications. In: Advances in cyanobacterial biology, pp 173–194
Kitts DD, Weiler K (2003) Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr Pharm 9:1309–1323
Kodani S, Ishida K, Murakami M (1998) Aeruginosin 103-A, a thrombin inhibitor from the cyanobacterium Microcystis viridis. J Nat Prod 61:1046–1048
KonÃcková R, Vanková K, VanÃková J, Vánová K, Muchová L, Subhanová I, VÃtek L (2014) Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compounds. Ann Hepatol 13:273–283
Kronick MN, Grossman PD (1983) Immunoassay techniques with fluorescent phycobiliprotein conjugates. Clin Chem 29:1582–1586
Kushak R, VanCott E, Drapeau C, Winter H (1999) Effect of algae Aphanizomenon flos aquae on digestive enzyme activity and polyunsaturated fatty acids level in blood plasma. Gastroenterology 4:A559–A559
Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H (2009) Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation. J Med Chem 52:5732–5747
Leung PO, Lee HH, Kung YC, Tsai MF, Chou TC (2013) Therapeutic effect of C-phycocyanin extracted from blue-green algae in a rat model of acute lung injury induced by lipopolysaccharide. eCAM
Liu Y, Xu L, Cheng N, Lin L, Zhang C (2000) Inhibitory effect of phycocyanin from Spirulina platensis on the growth of human leukaemia K562 cells. J Appl Phycol 12:125–130
Luesch H, Yoshida WY, Moore RE, Paul VJ, Mooberry SL, Corbett TH (2002) Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452. J Nat Prod 65:16–20
McCarty MF (2015) Hypothesis: Spirulina may slow the growth and spread of ovarian cancer by interfering with the growth factor activity of lysophosphatidic acid. J Mol Genet Med 9:184
McPhail KL, Correa J, Linington RG, González J, Ortega-BarrÃa E, Capson TL, Gerwick WH (2007) Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula. J Nat Prod 70:984–988
Michalak I, Chojnacka K (2015) Algae as production systems of bioactive compounds. Eng Life Sci 15:160–176
Mori T, Boyd MR (2001) Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4 and dissociates bound sgp120 from target cells. Antimicrob Agents Chemother 45:664–672
Morliere P, Maziere JC, Santus R (1998) Tolyporphin: a natural product from cyanobacteria with potent photosensitizing activity against tumour cells in vitro and in vivo. Cancer Res 58:3571–3578
Mukund S, Sivasubramanian V (2014) Anticancer activity of Oscillatoria terebriformis cyanobacteria in human lung cancer cell line a:549. Int J Appl Biol Pharm 5:2
Mundt S, Kreitlow S, Jansen R (2003) Fatty acids with antibacterial activity from the cyanobacterium Oscillatoria redekei HUB 051. J Appl Phycol 15:263–267
Muniaraj S, Subramanian V, Srinivasan P, Palani M (2018) In silico and in vitro studies on Lyngbya majuscula using against lung cancer cell line (A549). Pharm J 10:421
Murakami M, Okita Y, Matsuda H, Okino T, Yamaguchi K (1994) Aeruginosin 298-A, a thrombin and trypsin inhibitor from the blue-green alga Microcystis aeruginosa (NIES-298). Tetrahedron 35:3129–3132
Nowruzi B, Haghighat S, Fahimi H, Mohammadi E (2018) Nostoc cyanobacteria species: a new and rich source of novel bioactive compounds with pharmaceutical potential. J Pharm Health Serv Res 9:5–12
Okino T, Matsuda H, Murakami M, Yamaguchi K (1993) Microginin, an angiotensin-converting enzyme inhibitor from the blue-green alga Microcystis aeruginosa. Tetrahedron 34:501–504
Oyamada C, Kaneniwa M, Ebitani K, Murata M, Ishihara K (2008) Mycosporine-like amino acids extracted from scallop (Patinopecten yessoensis) ovaries: UV protection and growth stimulation activities on human cells. Mar Biotechnol 10:141–150
Pabon MM, Jernberg JN, Morganti J, Contreras J, Hudson CE, Klein RL, Bickford PC (2012) A spirulina-enhanced diet provides neuroprotection in an α-synuclein model of Parkinson’s disease
Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC (2013) Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res 73:2412–2417
Qiang HU, Zheungu H, Cohen Z, Richond A (1997) Enhancement of eicosapentaenoic acid (EPA) and γ-linolenic acid (GLA) production by manipulating the algal density of outdoor cultures of Monodus subterraneus (Eustigmatophyta) and Spirulina platensis (Cyanobacteria). Eur J Phycol 32:81–86
Qiu B, Liu J, Liu Z, Liu S (2002) Distribution and ecology of the edible cyanobacterium Ge-**an-Mi (Nostoc) in rice fields of Hefeng County in China. J Appl Phycol 14:423–429
Rasmussen HE, Blobaum KR, Park YK, Ehlers SJ, Lu F, Lee JY (2008) Lipid extract of Nostoc commune var. sphaeroides Kutzing, a blue-green alga, inhibits the activation of sterol regulatory element-binding proteins in HepG2 cells. Nutr J 138:476–481
Rasmussen HE, Blobaum KR, Jesch ED, Ku CS, Park YK, Lu F, Lee JY (2009) Hypocholesterolemic effect of Nostoc commune var. sphaeroides Kützing, an edible blue-green alga. Eur J Nutr 48:387–394
Rastogi RP, Incharoensakdi A (2014a) UV radiation-induced biosynthesis, stability and antioxidant activity of mycosporine-like amino acids (MAAs) in a unicellular cyanobacterium Gloeocapsa sp. CU2556. J Photochem Photobio B Bio 130:287–292
Rastogi RP, Incharoensakdi A (2014b) Characterization of UV-screening compounds, mycosporine-like amino acids, and scytonemin in the cyanobacterium Lyngbya sp. CU2555. FEMS Microbiol Ecol 87:244–256
Rastogi RP, Sinha RP, Incharoensakdi A (2013) Partial characterization, UV-induction and photoprotective function of sunscreen pigment, scytonemin from Rivularia sp. HKAR-4. Chemosphere 93:1874–1878
Reddy AS, Thomas TL (1996) Expression of a cyanobacterial Δ6-desaturase gene results in γ-linolenic acid production in transgenic plants. Nat Biotechnol 14:639–642
Reddy CM, Bhat VB, Kiranmai G, Reddy MN, Reddanna P, Madyastha KM (2000) Selective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis. Biochem Biophys Res Commun 277:599–603
Reinert RR, Low DE, Rossi F, Zhang X, Wattal C, Dowzicky MJ (2007) Antimicrobial susceptibility among organisms from the Asia/Pacific rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 60:1018–1029
Rickards RW, Rothschild JM, Willis AC, de Chazal NM, Kirk J, Kirk K, Smith GD (1999) Calothrixins A and B, novel pentacyclic metabolites from Calothrix cyanobacteria with potent activity against malaria parasites and human cancer cells. Tetrahedron 55:13513–13520
Rimbau V, Camins A, Pubill D, Sureda FX, Romay C, González R, Pallàs M (2001) C-phycocyanin protects cerebellargranule cells from low potassium/serum deprivation-induced apoptosis. Naunyn Schmiedeberg's Arch Pharmacol 364:96–104
Romay CH, Gonzalez R, Ledon N, Remirez D, Rimbau V (2003) C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Curr Protein Pept Sci 4:207–216
Sanchez LM, Lopez D, Vesely BA, Della Togna G, Gerwick WH, Kyle DE, Linington RG (2010) Almiramides A-C: Discovery and development of a new class of leishmaniasis lead compounds. J Med Chem 53:4187–4197
Sangthongpitag K, Delaney SF, Rogers PL (1996) Evaluation of four fresh-water unicellular cyanobacteria as potential hosts for mosquitocidal toxins. Biotechnol Lett 18:175–180
Sarmadi B, Ismail A, Hamid M (2011) Antioxidant and angiotensin-converting enzyme (ACE) inhibitory activities of cocoa (Theobroma cacao L.) autolysates. Food Res Int 44:290–296
Sasidharan S, Chen Y, Saravanan D, Sundram KM, Latha LY (2011) Extraction, isolation and characterization of bioactive compounds from plants’ extracts. Afr J Tradit Complement Altern Med 8
Seshadri CV (1993) All India coordinated project on Spirulina. Shri Amm Murugappa Chettiar Research Center (MCRC), Chennai
Sharma NK, Tiwari SP, Tripathi K, Rai AK (2011) Sustainability and cyanobacteria (blue-green algae): facts and challenges. J Appl Phycol 23:1059–1081
Simopoulos AP (1997) Nutrition tid-bites: essential fatty acids in health and chronic disease. Food Rev Int 13:623–631
Singh A, ČÞková M, BiÅ¡ová K, VÃtová M (2021) Exploring mycosporine-like amino acids (MAAs) as safe and natural protective agents against UV-induced skin damage. Antioxid 10:683
Stanier G (1988) Fine structure of cyanobacteria. In Meth Enzymol 167:157–172
Staunton J, Weissman KJ (2001) Polyketide biosynthesis: a millennium review. Nat Prod Rep 18:380–416
Stevenson CS, Capper EA, Roshak AK, Marquez B, Eichman C, Jackson JR, Marshall LA (2002a) The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore. J Pharmacol Exp Th 303:858–866
Stevenson CS, Capper EA, Roshak AK (2002b) Scytonemin-a marine natural product inhibitor of kinases key in hyperproliferative inflammatory diseases. Inflamm Res 51:112–114
Torres-Duran PV, Ferreira-Hermosillo A, Juarez-Oropeza MA (2007) Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report. Lipids Health Dis 6:1–8
Tyagi R, Kaushik BD, Kumar J (2014) Antimicrobial activity of some cyanobacteria. In: Microbial diversity and biotechnology in food security. Springer, New Delhi, pp 463–470
Vasas G, Borbely G, Nanasi P, Nanasi PP (2010) Alkaloids from cyanobacteria with diverse, potent bioactivities. Mini Rev Med Chem 10:946–955
Volk RB (2008) A newly developed assay for the quantitative determination of antimicrobial (anticyanobacterial) activity of both hydrophilic and lipophilic test compounds without any restriction. Microbiol Res 163:161–167
Volkmann M, Gorbushina AA, Kedar L, Oren A (2006) Structure of euhalothece-362, a novel red-shifted mycosporine-like amino acid, from a halophilic cyanobacterium (Euhalothece sp.). FEMS Microbiol Lett 258:50–54
Vonshak A (1997) Spirulina platensis arthrospira: physiology, cell-biology and biotechnology. CRC
Watanabe F, Takenaka S, Kittaka-Katsura H, Ebara S, Miyamoto E (2002) Characterization and bioavailability of vitamin B12-compounds from edible algae. J Nutr Sci Vitaminol 48:325–331
Whitton BA, Potts M (2007) The ecology of cyanobacteria: their diversity in time and space. Springer Science & Business Media
World Health Organization (2020) WHO report on cancer: setting priorities, investing wisely and providing care for all. World Health Organization, Geneva
Zahra Z, Choo DH, Lee H, Parveen A (2020) Cyanobacteria: review of current potentials and applications. Environments 7:13
Zainuddin EN, Mentel R, Wray V, Jansen R, Nimtz M, Lalk M, Mundt S (2007) Cyclic depsipeptides, ichthyopeptins A and B, from Microcystis ichthyoblabe. J Nat Prod 70:1084–1088
Zhang L, Li L, Wu Q (2007) Protective effects of mycosporine-like amino acids of Synechocystis sp. PCC 6803 and their partial characterization. J Photochem Photobiol 86:240–245
Acknowledgments
The authors are thankful to the Head of Centre of Advanced Study in Botany, Institute of Science, Banaras Hindu University, Varanasi, and DST-FIST for providing the necessary research facilities. The University Grants Commission, Government of India, New Delhi, is also acknowledged for providing Senior Research Fellowship (SRF) for financial assistance and ISLS, ISC, and BHU for instrumental facilities.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yadav, P., Singh, R.P., Kumar, A., Singh, P.K., Gupta, R.K. (2023). Therapeutic Potential of Cyanobacteria as a Producer of Novel Bioactive Compounds. In: Neilan, B., Passarini, M.R.Z., Singh, P.K., Kumar, A. (eds) Cyanobacterial Biotechnology in the 21st Century. Springer, Singapore. https://doi.org/10.1007/978-981-99-0181-4_13
Download citation
DOI: https://doi.org/10.1007/978-981-99-0181-4_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-0180-7
Online ISBN: 978-981-99-0181-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)